Net Cash Provided by (Used in) Financing Activities in USD of NOVAVAX INC from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Novavax Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to Q1 2025.
  • Novavax Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was -$7.06M, a 220% decline year-over-year.
  • Novavax Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was $261M, a 5735% increase from 2023.
  • Novavax Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $4.47M, a 98.6% decline from 2022.
  • Novavax Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $325M, a 29.6% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

NOVAVAX INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$7.06M -$12.9M -220% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q1 2024 $5.89M +$360M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q1 2023 -$354M -$514M -322% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q1 2022 $160M -$417M -72.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $577M +$391M +210% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $186M +$130M +231% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q1 2019 $56.2M +$12.3M +27.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q1 2018 $43.9M +$28.6M +186% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q1 2017 $15.4M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q1 2014 $1.17M -$6.01M -83.7% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-08
Q1 2013 $7.18M -$78K -1.08% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q1 2012 $7.26M +$5.91M +437% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q1 2011 $1.35M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09

NOVAVAX INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $261M +$256M +5735% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 $4.47M -$321M -98.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 $325M -$137M -29.6% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 $462M -$523M -53.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $985M +$886M +901% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $98.4M -$4.42M -4.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $103M +$38.3M +59.3% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $64.5M -$215M -76.9% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-11
2016 $280M +$71.6M +34.4% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-18
2015 $208M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-14
2012 $53.8M +$42.7M +383% Jan 1, 2012 Dec 31, 2012 10-K 2013-03-12
2011 $11.1M -$12.3M -52.5% Jan 1, 2011 Dec 31, 2011 10-K 2013-03-12
2010 $23.4M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.